Pharma · Public company · New York, NY, US
Pfizer Inc
Ticker PFE · SEC CIK 0000078003
Track this companyFree. Adds Pfizer Inc to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs37From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline37
- 20-valent pneumococcal conjugate vaccine (20vPnC)Phase 3 · Pneumococcal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 5-FUPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- AbrocitinibPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- BerobenatidePhase 3 · ApneaClinicalTrials.gov · fetched Nov 12, 2026
- CetuximabPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- DupilumabPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- EncorafenibPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- EtrasimodPhase 3 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- IrinotecanPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- LeucovorinPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- marstacimabPhase 3 · Hemophilia A or BClinicalTrials.gov · fetched Nov 12, 2026
- OxaliplatinPhase 3 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- PG4Phase 3 · Pneumococcal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Ritlecitinib higher dosePhase 3 · Severe Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- Ritlecitinib lower dosePhase 3 · Severe Alopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- RSVpreFPhase 3 · Respiratory Syncytial Virus (RSV)ClinicalTrials.gov · fetched Nov 12, 2026
- talazoparib plus enzalutamidePhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Talazoparib with enzalutamidePhase 3 · mCRPCClinicalTrials.gov · fetched Nov 12, 2026
- TilrekimigPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- 15-valent pneumococcal conjugate vaccine (PCV15)Phase 2 · Pneumococcal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Disitamab vedotinPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 2 · LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- FulvestrantPhase 2 · LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- GiredestrantPhase 2 · LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- LetrozolePhase 2 · LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- MidazolamPhase 2 · LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- PF-07220060Phase 2 · LiposarcomaClinicalTrials.gov · fetched Nov 12, 2026
- PF-07275315Phase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- RitlecitinibPhase 2 · Hidradenitis SuppurativaClinicalTrials.gov · fetched Nov 12, 2026
- BerobenatidePhase 1 · Overweight and/or ObesityClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 1 · Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PF-07832837Phase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- PF-08046876Phase 1 · Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- RitlecitinibAlopecia AreataClinicalTrials.gov · fetched Nov 12, 2026
- TIVDAKCervical CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic LeukemiaPHASE1_PHASE2 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07313852 · fetched Nov 12, 2026
- A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without InhibitorsPHASE3 · RECRUITING · started Oct 23, 2026ClinicalTrials.gov NCT07923981 · fetched Nov 12, 2026
- A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)PHASE3 · RECRUITING · started Oct 19, 2026ClinicalTrials.gov NCT07881757 · fetched Nov 12, 2026
- A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or ObesityPHASE1 · RECRUITING · started Oct 16, 2026ClinicalTrials.gov NCT07876531 · fetched Nov 12, 2026
- Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV DiseasePHASE3 · RECRUITING · started Sep 22, 2026ClinicalTrials.gov NCT07839871 · fetched Nov 12, 2026
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaPHASE3 · RECRUITING · started Aug 24, 2026ClinicalTrials.gov NCT07783425 · fetched Nov 12, 2026
- Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims DataACTIVE_NOT_RECRUITING · started Aug 17, 2026ClinicalTrials.gov NCT07821216 · fetched Nov 12, 2026
- A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsPHASE3 · RECRUITING · started May 4, 2026ClinicalTrials.gov NCT07573462 · fetched Nov 12, 2026
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaPHASE3 · RECRUITING · started Dec 2, 2025ClinicalTrials.gov NCT06807281 · fetched Nov 12, 2026
- A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 13, 2025ClinicalTrials.gov NCT07228390 · fetched Nov 12, 2026
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPHASE1 · RECRUITING · started Aug 20, 2025ClinicalTrials.gov NCT07090499 · fetched Nov 12, 2026
- A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia AreataPHASE3 · ACTIVE_NOT_RECRUITING · started Jul 31, 2025ClinicalTrials.gov NCT07029711 · fetched Nov 12, 2026
- A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast CancerPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 30, 2025ClinicalTrials.gov NCT06966453 · fetched Nov 12, 2026
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPHASE2 · RECRUITING · started May 20, 2025ClinicalTrials.gov NCT06977581 · fetched Nov 12, 2026
- Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPHASE4 · RECRUITING · started May 7, 2025ClinicalTrials.gov NCT06952660 · fetched Nov 12, 2026
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsPHASE1 · RECRUITING · started Nov 5, 2024ClinicalTrials.gov NCT06564389 · fetched Nov 12, 2026
- Characterization And Clinical Outcomes of AA Patients Treated With RitlecitinibACTIVE_NOT_RECRUITING · started Aug 7, 2024ClinicalTrials.gov NCT06531109 · fetched Nov 12, 2026
- A Study to Learn About How a New Pneumococcal Vaccine Works in InfantsPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 25, 2024ClinicalTrials.gov NCT06524414 · fetched Nov 12, 2026
- Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 27, 2024ClinicalTrials.gov NCT06106308 · fetched Nov 12, 2026
- Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCPHASE3 · ACTIVE_NOT_RECRUITING · started May 12, 2021ClinicalTrials.gov NCT04821622 · fetched Nov 12, 2026
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 21, 2020ClinicalTrials.gov NCT04607421 · fetched Nov 12, 2026
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsPHASE2 · RECRUITING · started Sep 23, 2020ClinicalTrials.gov NCT04557449 · fetched Nov 12, 2026
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative ColitisPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 5, 2019ClinicalTrials.gov NCT03950232 · fetched Nov 12, 2026
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPHASE1_PHASE2 · RECRUITING · started Mar 30, 2018ClinicalTrials.gov NCT03424005 · fetched Nov 12, 2026
- Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 18, 2017ClinicalTrials.gov NCT03395197 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 27, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Feb 26, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 3, 2026 · fetched Nov 12, 2026